Co-Diagnostics (CODX) Stock Statistics & Valuation Metrics

Co-Diagnostics has a market cap or net worth of $10.43M. The enterprise value is -$2.81M.

Co-Diagnostics has 33.57M shares outstanding. The number of shares has decreased by -2.65% in one year.

Co-Diagnostics’s return on equity (ROE) is -0.69 and return on invested capital (ROIC) is -69.69%.

The current PE Ratio of Co-Diagnostics is -0.60. Co-Diagnostics’s PEG ratio is -0.18.

In the last 12 months, Co-Diagnostics had revenue of $4.61M and earned -$41.28M in profits. Earnings per share was -$1.35.

In the last 12 months, operating cash flow was -$25.70M and capital expenditures -$1.14M, giving a free cash flow of -$26.84M billion.

Co-Diagnostics pays an annual dividend of , resulting in a dividend yield of

Co-Diagnostics upcoming earnings date is May 8, 2025, Before Open.

Co-Diagnostics as a current ratio of 4.41, with Debt / Equity ratio of 0.04

In the past 12 months, Co-Diagnostics has paid $3.90M in taxes.

Co-Diagnostics EV to EBITDA ratio is -0.61, with an EV/FCF ratio of -0.73.

Co-Diagnostics has $37.66M in cash and marketable securities with $2.37M in debt, giving a net cash position of -$35.29M billion.

Gross margin is 74.48%, with operating margin of -1023.75%, and net profit margin of -961.37%.

The average price target for Co-Diagnostics is $1.00, which is 11.43% higher than the current price. The consensus rating is Hold